Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
 
Program Contents
bullet Programs
Contact Info

English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760

International Travel
Phone: 1-887-394-8747
Contact CDC-INFO

Keep your kids healthy. cdc.gov/parents
 

Brainerd Diarrhea


Clinical Features Profuse and chronic watery diarrhea typically associated with urgency and incontinence that begins acutely and lasts from 2-36 months.
Etiologic Agent Unknown.
Incidence An estimated 5,000-8,000 patients with chronic diarrhea clinically similar to Brainerd diarrhea are cared for by U.S. gastroenterologists each year. Approximately every 3 years, CDC investigates an outbreak of Brainerd diarrhea affecting 50-100 people.
Sequelae No known sequelae; however, many people suffer adverse psychologic consequences related to the long duration of an incapacitating illness.
Transmission Untreated water has been implicated in several outbreaks and unpasteurized cow's milk has been implicated in one.
Risk Groups The elderly appear to be at greatest risk for Brainerd diarrhea, although several cases among children and young adults have been described.
Surveillance No surveillance system exists for Brainerd diarrhea or for other chronic diarrheal syndromes of unknown etiology (e.g., collagenous colitis, microscopic colitis).
Trends Data are insufficient to indicate an increase or decrease in incidence.
Challenges Despite numerous intensive laboratory investigations, the etiologic agent of Brainerd diarrhea remains a mystery. Histologic criteria for distinguishing Brainerd diarrhea from other chronic diarrheal syndromes were developed from outbreak-related specimens, but need to be evaluated in specimens from patients with sporadic cases of chronic idiopathic secretory diarrhea.
Opportunities Newer techniques, such as ribosomal RNA amplification on sterile site tissue biopsies may shed new light on the etiologic agent. The histologic criteria can be tested against specimens from a recent outbreak.

 

 
 
Date: October 6, 2005
Content source: National Center for Immunization and Respiratory Diseases: Division of Bacterial Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
English and Spanish: (800) CDC-INFO / (800) 232-4636
TTY: (888) 232-6348 / FAX: (770) 488-4760